Dr. Hülya Bayır was recently awarded a new $1.7 million, 5 year grant renewal from the National Institutes of Health for her project, “Oxidative Lipidomics in Pediatric Traumatic Brain Injury.”
Dr. Bayır’s project will identify the role of oxidized phospholipids in neuronal death after pediatric traumatic brain injury—a leading cause of death in children, amounting to almost 7400 deaths annually—using a state of the art oxidative lipidomics approach. Her team will test novel therapeutic compounds in experiments to prevent neuronal death, and to improve outcomes after pediatric TBI. Dr. Bayır’s project could lead to targeted therapies for TBI and ultimately improved outcomes for children. To read more on the NIH RePORT, click here.
Dr. Bayır is a Professor of Critical Care Medicine, Director of Research in Pediatric Critical Care Medicine, Associate Director of the Center for Free Radical and Antioxidant Health at the University of Pittsburgh Medical School, and Associate Director of the Safar Center for Resuscitation Research.
Congratulations to Dr. Bayır and her team!